查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1459597

全球內分泌檢測市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Endocrine Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 215 Pages | 商品交期: 最快1-2個工作天內

價格

全球內分泌檢測市場需求預計將從 2023 年的 126.1 億美元增至 2032 年近 285.4 億美元，2024-2032 年研究期間複合CAGR為 9.5%。

內分泌測試涉及評估內分泌系統的診斷程序，內分泌系統調節體內的荷爾蒙。這些測試測量血液、尿液或唾液樣本中的荷爾蒙水平，以檢測與糖尿病、甲狀腺疾病和生殖健康問題相關的異常或不平衡。它們有助於診斷和監測內分泌失調並指導適當的治療。

市場動態

糖尿病、甲狀腺疾病和荷爾蒙失衡等內分泌疾病的盛行率不斷上升，推動了對評估內分泌功能的診斷測試的需求。隨著全球慢性病盛行率持續上升，對內分泌疾病準確、及時診斷的需求日益成長。內分泌檢測是此過程中的重要工具，有助於早期發現和干涉，指導治療決策並改善患者的治療結果。此外，免疫分析、色譜和分子診斷等診斷技術的進步正在擴大內分泌檢測方法的能力和準確性，進一步推動市場成長。此外，人口老化的加劇以及以久坐行為和不健康飲食習慣為特徵的生活方式的改變導致內分泌疾病的增加，從而增加了對內分泌檢測服務的需求。此外，將內分泌檢測納入常規健康檢查和健康計劃可促進內分泌失調的早期發現和干涉，從而推動市場擴張。此外，政府為提高人們對內分泌健康的認知和改善醫療保健服務的可及性而採取的支持性舉措，透過促進內分泌疾病的常規檢測和篩檢，推動了市場的成長。然而，與先進測試方法、報銷限制和監管障礙相關的高成本可能會在一定程度上阻礙市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球內分泌檢測市場的每個細分市場進行包容性評估。內分泌檢測產業的成長和趨勢為本研究提供了整體方法。

市場區隔

內分泌檢測市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人群以及即將到來的機會。

按測試類型

  • 雌二醇（E2）測試
  • 卵泡刺激素 (Fsh) 測試
  • 人類絨毛膜促性腺激素 (Hcg) 荷爾蒙測試
  • 黃體生成素 (Lh) 測試
  • 硫酸脫氫表雄酮（Dheas）測試
  • 黃體酮測試
  • 睪酮測試
  • 促甲狀腺激素 (Tsh) 測試
  • 催乳素測試
  • 皮質醇測試
  • 胰島素測試
  • 其他

依技術

  • 串聯質譜法
  • 免疫分析
  • 單株和多株抗體抗體技術
  • 感測器技術
  • 臨床化學
  • 其他

按最終用途

  • 醫院
  • 商業實驗室
  • 門診護理中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲內分泌檢測市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。內分泌檢測市場的主要參與者包括 Abbott Laboratories、AB Sciex、Agilent Technologies Inc.、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Laboratory Corporation of America Holdings、Quest Diagnostics公司，Ortho 臨床診斷。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：內分泌檢測 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按測試類型進行的市場吸引力分析
    • 按技術分類的市場吸引力分析
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球內分泌檢測市場分析：依測試類型

  • 按測試類型概述
  • 歷史和預測數據
  • 按測試類型分析
  • 雌二醇（E2）測試
  • 卵泡刺激素 (FSH) 測試
  • 人類絨毛膜促性腺激素 (hCG) 荷爾蒙測試
  • 黃體生成素 (LH) 測試
  • 硫酸去氫表雄酮 (DHEAS) 測試
  • 黃體酮測試
  • 睪酮測試
  • 促甲狀腺激素 (TSH) 測試
  • 催乳素測試
  • 皮質醇測試
  • 胰島素測試
  • 其他

第 6 章：全球內分泌檢測市場分析：依技術分類

  • 依技術概述
  • 歷史和預測數據
  • 依技術分析
  • 串聯質譜法
  • 免疫分析
  • 單株和多株抗體抗體技術
  • 感測器技術
  • 臨床化學
  • 其他

第 7 章：全球內分泌檢測市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 歷史和預測數據
  • 按最終用途分析
  • 醫院
  • 商業實驗室
  • 門診護理中心
  • 其他

第 8 章：全球內分泌檢測市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 9 章：內分泌檢測公司的競爭格局

  • 內分泌檢測市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 10 章：公司簡介

  • 公司股份分析
  • 市場集中度
  • Abbott Laboratories
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AB Sciex
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Agilent Technologies Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • bioMerieux SA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Bio-Rad Laboratories Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • DiaSorin SpA
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • F. Hoffmann-La Roche Ltd.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Laboratory Corporation of America Holdings
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Quest Diagnostics Inc.
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Ortho Clinical Diagnostics
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR112114091

The global demand for Endocrine Testing Market is presumed to reach the market size of nearly USD 28.54 Billion by 2032 from USD 12.61 Billion in 2023 with a CAGR of 9.5% under the study period 2024 - 2032.

Endocrine testing involves diagnostic procedures to assess the endocrine system, which regulates hormones within the body. These tests measure hormone levels in blood, urine, or saliva samples to detect abnormalities or imbalances related to diabetes, thyroid disorders, and reproductive health issues. They aid in diagnosing and monitoring endocrine disorders and guiding appropriate treatment.

MARKET DYNAMICS

The growing prevalence of endocrine disorders, like diabetes, thyroid disorders, and hormonal imbalances, is driving the demand for diagnostic tests to assess endocrine function. With the ongoing global prevalence of chronic diseases continuing to rise, there is a growing need for accurate and timely diagnosis of endocrine disorders. Endocrine testing, a crucial tool in this process, aids in early detection and intervention, guiding treatment decisions and improving patient outcomes. Moreover, advancements in diagnostic technologies, such as immunoassays, chromatography, and molecular diagnostics, are expanding the capabilities and accuracy of endocrine testing methods, further driving market growth. Additionally, the growing aging population and changing lifestyles characterized by sedentary behavior and unhealthy dietary habits contribute to the rise in endocrine disorders, increasing the demand for endocrine testing services. Furthermore, integrating endocrine testing into routine health screenings and wellness programs drives market expansion by facilitating early detection and intervention for endocrine disorders. Moreover, supportive government initiatives to raise awareness about endocrine health and improve access to healthcare services are fueling market growth by promoting routine testing and screening for endocrine disorders. However, high costs associated with advanced testing methods, reimbursement constraints, and regulatory hurdles will likely hinder market growth to some extent.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of endocrine testing. The growth and trends of endocrine testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the endocrine testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Test Type

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (Fsh) Test
  • Human Chorionic Gonadotropin (Hcg) Hormone Test
  • Luteinizing Hormone (Lh) Test
  • Dehydroepiandrosterone Sulfate (Dheas) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (Tsh) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others

By Technology

  • Tandem Mass Spectrometry
  • Immunoassay
  • Monoclonal & Polyclonal Antibody Technologies
  • Sensor Technology
  • Clinical Chemistry
  • Others

By End-Use

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Endocrine Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Endocrine Testing market include Abbott Laboratories, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Ortho Clinical Diagnostics. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ENDOCRINE TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Test Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By End-use
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY TEST TYPE

  • 5.1 Overview by Test Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Test Type
  • 5.4 Estradiol (E2) Test Historic and Forecast Sales by Regions
  • 5.5 Follicle Stimulating Hormone (FSH) Test Historic and Forecast Sales by Regions
  • 5.6 Human Chorionic Gonadotropin (hCG) Hormone Test Historic and Forecast Sales by Regions
  • 5.7 Luteinizing Hormone (LH) Test Historic and Forecast Sales by Regions
  • 5.8 Dehydroepiandrosterone Sulfate (DHEAS) Test Historic and Forecast Sales by Regions
  • 5.9 Progesterone Test Historic and Forecast Sales by Regions
  • 5.10. Testosterone Test Historic and Forecast Sales by Regions
  • 5.11 Thyroid Stimulating Hormone (TSH) Test Historic and Forecast Sales by Regions
  • 5.12 Prolactin Test Historic and Forecast Sales by Regions
  • 5.13 Cortisol Test Historic and Forecast Sales by Regions
  • 5.14 Insulin Test Historic and Forecast Sales by Regions
  • 5.15 Others Historic and Forecast Sales by Regions

6 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1 Overview by Technology
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Technology
  • 6.4 Tandem Mass Spectrometry Historic and Forecast Sales by Regions
  • 6.5 Immunoassay Historic and Forecast Sales by Regions
  • 6.6 Monoclonal & Polyclonal Antibody Technologies Historic and Forecast Sales by Regions
  • 6.7 Sensor Technology Historic and Forecast Sales by Regions
  • 6.8 Clinical Chemistry Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY END-USE

  • 7.1 Overview by End-use
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-use
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Commercial Laboratories Historic and Forecast Sales by Regions
  • 7.6 Ambulatory Care Centers Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL ENDOCRINE TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ENDOCRINE TESTING COMPANIES

  • 9.1. Endocrine Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ENDOCRINE TESTING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott Laboratories
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. AB Sciex
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Agilent Technologies Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. bioMerieux SA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Bio-Rad Laboratories Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. DiaSorin S.p.A.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Laboratory Corporation of America Holdings
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Quest Diagnostics Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Ortho Clinical Diagnostics
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Test Type (USD MN)
  • Estradiol (E2) Test Market Sales by Geography (USD MN)
  • Follicle Stimulating Hormone (FSH) Test Market Sales by Geography (USD MN)
  • Human Chorionic Gonadotropin (hCG) Hormone Test Market Sales by Geography (USD MN)
  • Luteinizing Hormone (LH) Test Market Sales by Geography (USD MN)
  • Dehydroepiandrosterone Sulfate (DHEAS) Test Market Sales by Geography (USD MN)
  • Progesterone Test Market Sales by Geography (USD MN)
  • Testosterone Test Market Sales by Geography (USD MN)
  • Thyroid Stimulating Hormone (TSH) Test Market Sales by Geography (USD MN)
  • Prolactin Test Market Sales by Geography (USD MN)
  • Cortisol Test Market Sales by Geography (USD MN)
  • Insulin Test Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Technology (USD MN)
  • Tandem Mass Spectrometry Market Sales by Geography (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Monoclonal & Polyclonal Antibody Technologies Market Sales by Geography (USD MN)
  • Sensor Technology Market Sales by Geography (USD MN)
  • Clinical Chemistry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Commercial Laboratories Market Sales by Geography (USD MN)
  • Ambulatory Care Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Endocrine Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Endocrine Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Endocrine Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Test Type
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Test Type (USD MN)
  • Estradiol (E2) Test Market Sales by Geography (USD MN)
  • Follicle Stimulating Hormone (FSH) Test Market Sales by Geography (USD MN)
  • Human Chorionic Gonadotropin (hCG) Hormone Test Market Sales by Geography (USD MN)
  • Luteinizing Hormone (LH) Test Market Sales by Geography (USD MN)
  • Dehydroepiandrosterone Sulfate (DHEAS) Test Market Sales by Geography (USD MN)
  • Progesterone Test Market Sales by Geography (USD MN)
  • Testosterone Test Market Sales by Geography (USD MN)
  • Thyroid Stimulating Hormone (TSH) Test Market Sales by Geography (USD MN)
  • Prolactin Test Market Sales by Geography (USD MN)
  • Cortisol Test Market Sales by Geography (USD MN)
  • Insulin Test Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Technology (USD MN)
  • Tandem Mass Spectrometry Market Sales by Geography (USD MN)
  • Immunoassay Market Sales by Geography (USD MN)
  • Monoclonal & Polyclonal Antibody Technologies Market Sales by Geography (USD MN)
  • Sensor Technology Market Sales by Geography (USD MN)
  • Clinical Chemistry Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Commercial Laboratories Market Sales by Geography (USD MN)
  • Ambulatory Care Centers Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.